<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="d.o.o., SarajevoBosnia and Herzegovina pmcid: 7428924MSM-32-158 doi: 10.5455/msm.2020.32.158-164 : Review" exact="Cardiovascular Diseases" post="(CVDs) in COVID-19 Pandemic Era GercVjekoslav1MasicIzet1SalihefendicNizama2ZildzicMuharem1[1], [2], Corresponding author:"/>
 <result pre="SarajevoBosnia and Herzegovina pmcid: 7428924MSM-32-158 doi: 10.5455/msm.2020.32.158-164 : Review Cardiovascular" exact="Diseases" post="(CVDs) in COVID-19 Pandemic Era GercVjekoslav1MasicIzet1SalihefendicNizama2ZildzicMuharem1[1], [2], Corresponding author:"/>
 <result pre="original work is properly cited. Abstract Introduction: COVID-19 is the" exact="disease" post="caused by an infection of the SARS-CoV-2 virus, previously"/>
 <result pre="cited. Abstract Introduction: COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, previously known as 2019 Novel"/>
 <result pre="the SARS-CoV-2 virus, previously known as 2019 Novel Coronavirus (2019-nCoV)" exact="respiratory" post="disease. World Health Organization (WHO) declared the official name"/>
 <result pre="of this study is to retreive published papers about COVID-19" exact="infection" post="deposited in PubMed data base and analyzed current results"/>
 <result pre="investigations regarding morbidity and mortality rates as consequences of COVID-19" exact="infection" post="and opinions of experts about treatment of afected patients"/>
 <result pre="cleaning and disinfecting frequently touched surfaces can help prevent coronavirus" exact="infections" post="are the main proposal of WHO experts in current"/>
 <result pre="COVID-19 CVDs WHO ESC Guidelines 1. INTRODUCTION COVID-19 is the" exact="disease" post="caused by an infection of the SARS-CoV-2 virus, first"/>
 <result pre="Guidelines 1. INTRODUCTION COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, first identified in the city"/>
 <result pre="2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV)," exact="respiratory" post="disease before the World Health Organization (WHO) declared the"/>
 <result pre="COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV), respiratory" exact="disease" post="before the World Health Organization (WHO) declared the official"/>
 <result pre="in February 2020 (1, 2). COVID-19 spreads by contact with" exact="respiratory" post="droplets that spread when an infected person coughs or"/>
 <result pre="droplets that spread when an infected person coughs or sneezes." exact="Respiratory" post="virus infection is a major source of global pandemics"/>
 <result pre="that spread when an infected person coughs or sneezes. Respiratory" exact="virus infection" post="is a major source of global pandemics as a"/>
 <result pre="spread when an infected person coughs or sneezes. Respiratory virus" exact="infection" post="is a major source of global pandemics as a"/>
 <result pre="source of global pandemics as a consequence of swift human-to-human" exact="respiratory" post="tract transmission. Within the past two decades, coronaviruses and"/>
 <result pre="2.254 patients in 27 countries (1). Besides coronaviruses, avian and" exact="swine influenza" post="remain a concern for global public health in the"/>
 <result pre="were 18.500 laboratory-confirmed deaths and more than 200.000 deaths from" exact="respiratory" post="disease worldwide (1). In late 2019, a cohort of"/>
 <result pre="18.500 laboratory-confirmed deaths and more than 200.000 deaths from respiratory" exact="disease" post="worldwide (1). In late 2019, a cohort of patients"/>
 <result pre="(1). In late 2019, a cohort of patients presenting with" exact="pneumonia" post="of varying acuity and unknown aetiology in Wuhan, China,"/>
 <result pre="of COVID-19. Although COVID-19 appears to have greater infectivity and" exact="lower" post="mortality than SARS and MERS, many uncertainties (including route"/>
 <result pre="than SARS and MERS, many uncertainties (including route of infection," exact="viral" post="evolution, epidemic dynamics, appropriate anti-viral treatment and strategies for"/>
 <result pre="viral evolution, epidemic dynamics, appropriate anti-viral treatment and strategies for" exact="disease" post="control) remain. Since there is no cure for this"/>
 <result pre="disease control) remain. Since there is no cure for this" exact="viral" post="disease and a long wait is needed to find"/>
 <result pre="control) remain. Since there is no cure for this viral" exact="disease" post="and a long wait is needed to find a"/>
 <result pre="are justified, as experts point to procedures that curb a" exact="Severe" post="Acute Respiratory Syndrome (SARS) caused by another type of"/>
 <result pre="justified, as experts point to procedures that curb a Severe" exact="Acute" post="Respiratory Syndrome (SARS) caused by another type of virus"/>
 <result pre="as experts point to procedures that curb a Severe Acute" exact="Respiratory" post="Syndrome (SARS) caused by another type of virus Corona"/>
 <result pre="experts point to procedures that curb a Severe Acute Respiratory" exact="Syndrome" post="(SARS) caused by another type of virus Corona (2-4)."/>
 <result pre="Corona (2-4). CVDs may become unstable in the setting of" exact="viral infection" post="as a consequence of imbalance between infection-induced increasing in"/>
 <result pre="(2-4). CVDs may become unstable in the setting of viral" exact="infection" post="as a consequence of imbalance between infection-induced increasing in"/>
 <result pre="31st, 2020, 390.423 persons worldwide died as consequences of COVID-19" exact="infection" post="and total number of infected people was 6,647.258 citizens."/>
 <result pre="390.423 persons worldwide died as consequences of COVID-19 infection and" exact="total" post="number of infected people was 6,647.258 citizens. Web Portal"/>
 <result pre="and total number of infected people was 6,647.258 citizens. Web" exact="Portal" post="â€œWorldometerâ€œ announced up-dated picture of global epidemiological facts since"/>
 <result pre="2. THE CARDIOVASCULAR DISEASES (CVD) IN THE COVID-19 ERA COVID-19" exact="infection" post="is caused by a new beta-coronavirus, which the WHO"/>
 <result pre="a new beta-coronavirus, which the WHO has called (SARS-CoV-2) -" exact="Severe" post="Acute Respiratory Syndrome. Coronavirus 2 is a disease that"/>
 <result pre="new beta-coronavirus, which the WHO has called (SARS-CoV-2) - Severe" exact="Acute" post="Respiratory Syndrome. Coronavirus 2 is a disease that appeared"/>
 <result pre="beta-coronavirus, which the WHO has called (SARS-CoV-2) - Severe Acute" exact="Respiratory" post="Syndrome. Coronavirus 2 is a disease that appeared in"/>
 <result pre="(SARS-CoV-2) - Severe Acute Respiratory Syndrome. Coronavirus 2 is a" exact="disease" post="that appeared in December 2019 in the Chinese city"/>
 <result pre="spread very quickly beyond the borders of China. In a" exact="short" post="period of time, it took on all the characteristics"/>
 <result pre="mortality - up to 50% of hospitalized patients have a" exact="chronic" post="medical illness (40% cardiovascular or cerebrovascular disease). In the"/>
 <result pre="50% of hospitalized patients have a chronic medical illness (40%" exact="cardiovascular" post="or cerebrovascular disease). In the largest published clinical cohort"/>
 <result pre="In the largest published clinical cohort of COVID-19 to date," exact="acute" post="cardiac injury, shock and arrhythmia were presented in 7.2%,"/>
 <result pre="cohort of COVID-19 to date, acute cardiac injury, shock and" exact="arrhythmia" post="were presented in 7.2%, 8.7%, and 16.7% of patients,"/>
 <result pre="quickly observed that COVID-19 is attacking many organs, including the" exact="heart" post="muscle, vascular endothelium and the cardiovascular system in general,"/>
 <result pre="that COVID-19 is attacking many organs, including the heart muscle," exact="vascular" post="endothelium and the cardiovascular system in general, increasing morbidity"/>
 <result pre="many organs, including the heart muscle, vascular endothelium and the" exact="cardiovascular" post="system in general, increasing morbidity and mortality, especially in"/>
 <result pre="general, increasing morbidity and mortality, especially in patients with other" exact="cardiovascular" post="risk factors presented (hypertension, diabetes, obesity, cerebrovascular and renal"/>
 <result pre="In a significant number of infected patients, severe myocardial damage," exact="malignant" post="arrhythmias and cardiac arrest occurred. Itâ€™s interesting, SARS-CoV-2 can"/>
 <result pre="number of infected patients, severe myocardial damage, malignant arrhythmias and" exact="cardiac arrest" post="occurred. Itâ€™s interesting, SARS-CoV-2 can also lead to neurological"/>
 <result pre="appearance of hyposmia or anosmia (6). The virus damages the" exact="nerve" post="endings in the olfactory epithelium and damages the olfactory"/>
 <result pre="the nerves and then damage them. It happens that the" exact="peripheral" post="nerves are also affected, which manifests itself in the"/>
 <result pre="cerebrovascular diseases. So, SARS-CoV-2 is neuroinvasive and can penetrate the" exact="brain" post="and lead to neuronal death (6). It is interesting"/>
 <result pre="is neuroinvasive and can penetrate the brain and lead to" exact="neuronal" post="death (6). It is interesting to mention that in"/>
 <result pre="nausea and diarrhea. Cardiovascular complications of influenza infection, including myocarditis," exact="acute" post="myocardial infarction and exacerbation of heart failure have been"/>
 <result pre="and diarrhea. Cardiovascular complications of influenza infection, including myocarditis, acute" exact="myocardial infarction" post="and exacerbation of heart failure have been well-recognized during"/>
 <result pre="influenza infection, including myocarditis, acute myocardial infarction and exacerbation of" exact="heart" post="failure have been well-recognized during previous historical epidemics and"/>
 <result pre="coronavirus outbreaks have been associated with a significant burden of" exact="cardiovascular" post="comorbidities and complications. 3. COVID-19 IS A SYSTEMIC DISEASE"/>
 <result pre="DISEASE The afore-mentioned clinical manifestations suggest that COVID-19 is a" exact="systemic" post="disease, that it is characterized by numerous tissues and"/>
 <result pre="the manifestation of various clinical symptoms. At the same time," exact="vascular" post="endothelial dysfunction and coagulopathy occur (7). Inflammation of the"/>
 <result pre="clinical symptoms. At the same time, vascular endothelial dysfunction and" exact="coagulopathy" post="occur (7). Inflammation of the endothelium severely impairs its"/>
 <result pre="which in turn causes further complications (4), but also to" exact="systemic" post="endothelial inflammation. Namely, the virus directly attacks the endothelial"/>
 <result pre="inflammation. Namely, the virus directly attacks the endothelial cells of" exact="blood vessels." post="Induce endothelial damage in the small and smallest blood"/>
 <result pre="blood vessels. Induce endothelial damage in the small and smallest" exact="blood vessels" post="of the lungs and leads to an enhanced inflammatory"/>
 <result pre="of transplantation. During the autopsy, a significant increase in new" exact="blood vessels" post="was found in the lungs of the patient with"/>
 <result pre="found in the lungs of the patient with COVID-19, through" exact="intussusception" post="angiogenesis. Therefore, there is a comprehensive inflammation of the"/>
 <result pre="microcirculation disorders occur that damage of the heart, lead to" exact="pulmonary embolism" post="and clog blood vessels in the brain and digestive"/>
 <result pre="damage of the heart, lead to pulmonary embolism and clog" exact="blood vessels" post="in the brain and digestive system. Multiple organ failure"/>
 <result pre="lead to pulmonary embolism and clog blood vessels in the" exact="brain" post="and digestive system. Multiple organ failure occurs, ultimately resulting"/>
 <result pre="and clog blood vessels in the brain and digestive system." exact="Multiple" post="organ failure occurs, ultimately resulting in death. Systemic inflammation"/>
 <result pre="digestive system. Multiple organ failure occurs, ultimately resulting in death." exact="Systemic" post="inflammation promotes thrombosis. Massive inflammation stimulates the production of"/>
 <result pre="is 2-4 g/L. Endothelial cells located on the inside of" exact="blood vessels" post="have ACE-2 receptors on their surface, which serve as"/>
 <result pre="time. This explains why thromboembolic complications occur so frequently, including" exact="pulmonary embolism." post="Many patients have increased D-dimer values as well as"/>
 <result pre="embolism. Many patients have increased D-dimer values as well as" exact="cutaneous" post="changes in the limbs, suggesting thrombotic microangiopathy. Diffuse intravascular"/>
 <result pre="well as cutaneous changes in the limbs, suggesting thrombotic microangiopathy." exact="Diffuse" post="intravascular coagulation and thrombosis of large blood vessels are"/>
 <result pre="in the limbs, suggesting thrombotic microangiopathy. Diffuse intravascular coagulation and" exact="thrombosis" post="of large blood vessels are associated with multisystem organ"/>
 <result pre="suggesting thrombotic microangiopathy. Diffuse intravascular coagulation and thrombosis of large" exact="blood vessels" post="are associated with multisystem organ failure. Renal blood vessels"/>
 <result pre="of large blood vessels are associated with multisystem organ failure." exact="Renal" post="blood vessels are often involved and ACE-2 receptors are"/>
 <result pre="large blood vessels are associated with multisystem organ failure. Renal" exact="blood vessels" post="are often involved and ACE-2 receptors are known to"/>
 <result pre="SARS-CoV-2 not only attacks the lungs, but also affects the" exact="blood vessels" post="of all organs. COVID-19 is a systemic inflammation of"/>
 <result pre="affects the blood vessels of all organs. COVID-19 is a" exact="systemic" post="inflammation of the blood vessels, so we could see"/>
 <result pre="of all organs. COVID-19 is a systemic inflammation of the" exact="blood vessels," post="so we could see the whole clinical picture as"/>
 <result pre="at the same time to protect and stabilize the patientâ€™s" exact="blood vessels." post="This is especially true for patients who already have"/>
 <result pre="vessels. This is especially true for patients who already have" exact="cardiovascular disease" post="and some of the risk factors (hypertension, diabetes, increased"/>
 <result pre="This is especially true for patients who already have cardiovascular" exact="disease" post="and some of the risk factors (hypertension, diabetes, increased"/>
 <result pre="easily resist the attack of the virus. COVID-19 is a" exact="primary" post="respiratory disease, but many patients have cardiovascular disease, including"/>
 <result pre="resist the attack of the virus. COVID-19 is a primary" exact="respiratory" post="disease, but many patients have cardiovascular disease, including the"/>
 <result pre="COVID-19 is a primary respiratory disease, but many patients have" exact="cardiovascular disease," post="including the hypertension, acute heart damage and myocarditis. Acute"/>
 <result pre="disease, but many patients have cardiovascular disease, including the hypertension," exact="acute" post="heart damage and myocarditis. Acute lung damage leads to"/>
 <result pre="but many patients have cardiovascular disease, including the hypertension, acute" exact="heart" post="damage and myocarditis. Acute lung damage leads to increased"/>
 <result pre="cardiovascular disease, including the hypertension, acute heart damage and myocarditis." exact="Acute" post="lung damage leads to increased heart rate, which then"/>
 <result pre="heart damage and myocarditis. Acute lung damage leads to increased" exact="heart" post="rate, which then presents an additional problem, especially for"/>
 <result pre="then presents an additional problem, especially for patients with pre-existing" exact="heart" post="insuficiency. Cardiovascular disease can be primary if we take"/>
 <result pre="additional problem, especially for patients with pre-existing heart insuficiency. Cardiovascular" exact="disease" post="can be primary if we take into account the"/>
 <result pre="for patients with pre-existing heart insuficiency. Cardiovascular disease can be" exact="primary" post="if we take into account the activity of the"/>
 <result pre="angiotensin converting enzyme (ACE-2), which is also present in the" exact="heart" post="itself. 4. COVID-19 AND CARDIOVASCULAR DISEASES SARS-CoV-2, not only"/>
 <result pre="CARDIOVASCULAR DISEASES SARS-CoV-2, not only leads to damage of the" exact="respiratory" post="system, but also to acute and chronic damage to"/>
 <result pre="leads to damage of the respiratory system, but also to" exact="acute" post="and chronic damage to the cardiovascular system (4). Cardiovascular"/>
 <result pre="damage of the respiratory system, but also to acute and" exact="chronic" post="damage to the cardiovascular system (4). Cardiovascular diseases that"/>
 <result pre="system, but also to acute and chronic damage to the" exact="cardiovascular" post="system (4). Cardiovascular diseases that were present before a"/>
 <result pre="patients. This especially refers to the presence of hypertension, diabetes," exact="coronary heart disease" post="and kidney disease. Patients with acute coronary syndrome, who"/>
 <result pre="This especially refers to the presence of hypertension, diabetes, coronary" exact="heart" post="disease and kidney disease. Patients with acute coronary syndrome,"/>
 <result pre="especially refers to the presence of hypertension, diabetes, coronary heart" exact="disease" post="and kidney disease. Patients with acute coronary syndrome, who"/>
 <result pre="to the presence of hypertension, diabetes, coronary heart disease and" exact="kidney disease." post="Patients with acute coronary syndrome, who are infected with"/>
 <result pre="hypertension, diabetes, coronary heart disease and kidney disease. Patients with" exact="acute" post="coronary syndrome, who are infected with SARS-CoV-2 virus, have"/>
 <result pre="such patients, the functional cardiac reserve is reduced due to" exact="myocardial ischemia" post="or necrosis. At the same time, the possibility that"/>
 <result pre="patients, the functional cardiac reserve is reduced due to myocardial" exact="ischemia" post="or necrosis. At the same time, the possibility that"/>
 <result pre="the same time, the possibility that these patients will develop" exact="heart" post="failure is quite high. Respiratory failure and hypoxia can"/>
 <result pre="that these patients will develop heart failure is quite high." exact="Respiratory" post="failure and hypoxia can lead to myocardial damage as"/>
 <result pre="will develop heart failure is quite high. Respiratory failure and" exact="hypoxia" post="can lead to myocardial damage as well as the"/>
 <result pre="of Chinese physicians, in patients infected with COVID-19 and with" exact="acute" post="coronary syndrome, the complete clinical picture was very severe"/>
 <result pre="patients infected with COVID-19 and with acute coronary syndrome, the" exact="complete" post="clinical picture was very severe and associated with high"/>
 <result pre="associated with high mortality (9). If patients already suffer from" exact="heart" post="failure, infection with COVID-19 leads to worsening their health"/>
 <result pre="high mortality (9). If patients already suffer from heart failure," exact="infection" post="with COVID-19 leads to worsening their health condition and"/>
 <result pre="condition and not seldomly to death. On the other hand," exact="acute" post="inflammatory responses can lead to ischemia in the presence"/>
 <result pre="On the other hand, acute inflammatory responses can lead to" exact="ischemia" post="in the presence of pre-existing cardiovascular disease. The inflammatory"/>
 <result pre="responses can lead to ischemia in the presence of pre-existing" exact="cardiovascular disease." post="The inflammatory activity of atherosclerotic plaque in coronary blood"/>
 <result pre="cardiovascular disease. The inflammatory activity of atherosclerotic plaque in coronary" exact="blood vessels" post="becomes even more pronounced during systemic inflammation, which makes"/>
 <result pre="plaque in coronary blood vessels becomes even more pronounced during" exact="systemic" post="inflammation, which makes atherosclerotic plaque more vulnerable and thus"/>
 <result pre="then an intense inflammatory response, along with the already present" exact="cardiovascular disease," post="can contribute to heart damage. Vascular endothelial cell dysfunction"/>
 <result pre="along with the already present cardiovascular disease, can contribute to" exact="heart" post="damage. Vascular endothelial cell dysfunction in the presence of"/>
 <result pre="the already present cardiovascular disease, can contribute to heart damage." exact="Vascular" post="endothelial cell dysfunction in the presence of inflammation, and"/>
 <result pre="to its worsening, if it has been presented before. Myocarditis," exact="pericarditis" post="and arrhythmias can also occur. Rhythm disorders are manifested"/>
 <result pre="are manifested in the form of bradycardia, tachycardia and paroxysmal" exact="atrial fibrillation." post="The occurrence of myocarditis is the result of focal"/>
 <result pre="of bradycardia, tachycardia and paroxysmal atrial fibrillation. The occurrence of" exact="myocarditis" post="is the result of focal or global inflammation of"/>
 <result pre="atrial fibrillation. The occurrence of myocarditis is the result of" exact="focal" post="or global inflammation of the myocardium, necrosis and ventricular"/>
 <result pre="of focal or global inflammation of the myocardium, necrosis and" exact="ventricular dysfunction." post="Inflammation, by itself, plays an important role in the"/>
 <result pre="an important role in the onset, development and prognosis of" exact="cardiovascular disease." post="The virus can penetrate directly into the myocardium and"/>
 <result pre="to its damage, necrosis and apoptosis (programmed cell death). Focal" exact="myocarditis" post="should be considered if precordial pain occurs during and"/>
 <result pre="be considered if precordial pain occurs during and after the" exact="acute" post="phase of COVID-19, with clinical signs that would suggest"/>
 <result pre="as other inflammatory cytokines, have become new risk factors. Cardiovascular" exact="disease" post="and cardiovascular risk factors represent an independent risk factor"/>
 <result pre="inflammatory cytokines, have become new risk factors. Cardiovascular disease and" exact="cardiovascular" post="risk factors represent an independent risk factor for cardiac"/>
 <result pre="8-28% of patients infected with the SARS-CoV-2 virus, indicating that" exact="heart" post="damage has occurred. Increased values of troponin and its"/>
 <result pre="with the SARS-CoV-2 virus, indicating that heart damage has occurred." exact="Increased" post="values of troponin and its dynamic increase during hospitalization,"/>
 <result pre="5 times. All of the above explains the connection between" exact="cardiovascular" post="diseases and the occurrence of death in patients suffering"/>
 <result pre="suffering from COVID-19. Many patients infected with COVID-19 die from" exact="cardiac arrest" post="due to severe hypoxia, multiorgan dysfunction, or systemic inflammation."/>
 <result pre="from cardiac arrest due to severe hypoxia, multiorgan dysfunction, or" exact="systemic" post="inflammation. The occurrence of arrhythmias, such as atrial fibrillation,"/>
 <result pre="dysfunction, or systemic inflammation. The occurrence of arrhythmias, such as" exact="atrial fibrillation," post="often occurs as part of COVID-19 cardiomyopathy, among other"/>
 <result pre="inflammation is a substrate for the occurrence of arrhythmias (11)." exact="Ventricular" post="arrhythmias occur, which can also be an introduction to"/>
 <result pre="Ventricular arrhythmias occur, which can also be an introduction to" exact="cardiac arrest." post="QT prolongation may occur as part of myocarditis, as"/>
 <result pre="same time, there were ventricular arrhythmias and mortality increased. 6." exact="HEART" post="IN A CYTOKINE STORM Cytokine storm syndrome is a"/>
 <result pre="mortality increased. 6. HEART IN A CYTOKINE STORM Cytokine storm" exact="syndrome" post="is a dysregulation of the immune system, and the"/>
 <result pre="do all this. As SARS-CoV-2 infiltrates the cells of the" exact="respiratory" post="system, it can thus hide better from our immune"/>
 <result pre="cells in our body, but so our immune system (12)." exact="Acute" post="myocarditis, cardiac decompensation, or cardiogenic shock can occur during"/>
 <result pre="so our immune system (12). Acute myocarditis, cardiac decompensation, or" exact="cardiogenic shock" post="can occur during a cytokine storm. Inflammatory cells in"/>
 <result pre="decompensation, or cardiogenic shock can occur during a cytokine storm." exact="Inflammatory" post="cells in the presence of hypercytokinemia infiltrate the heart."/>
 <result pre="There is a release of troponin and an increase in" exact="brain" post="natriuretic peptide (BNP). Inflammatory cytokine storm is accompanied by"/>
 <result pre="of troponin and an increase in brain natriuretic peptide (BNP)." exact="Inflammatory" post="cytokine storm is accompanied by immunopathological changes in the"/>
 <result pre="in the lungs. Patients infected with SARS-CoV-2 mostly die from" exact="Acute" post="Respiratory Distress Syndrome (ARDS) (4). This leads to acute"/>
 <result pre="the lungs. Patients infected with SARS-CoV-2 mostly die from Acute" exact="Respiratory" post="Distress Syndrome (ARDS) (4). This leads to acute pneumonia"/>
 <result pre="Patients infected with SARS-CoV-2 mostly die from Acute Respiratory Distress" exact="Syndrome" post="(ARDS) (4). This leads to acute pneumonia and to"/>
 <result pre="from Acute Respiratory Distress Syndrome (ARDS) (4). This leads to" exact="acute" post="pneumonia and to accumulation of fluid in the lungs,"/>
 <result pre="Acute Respiratory Distress Syndrome (ARDS) (4). This leads to acute" exact="pneumonia" post="and to accumulation of fluid in the lungs, which"/>
 <result pre="after the onset of infection. Unfortunately, 40% of patients with" exact="acute" post="respiratory distress syndrome do not survive. At the same"/>
 <result pre="the onset of infection. Unfortunately, 40% of patients with acute" exact="respiratory" post="distress syndrome do not survive. At the same time,"/>
 <result pre="of infection. Unfortunately, 40% of patients with acute respiratory distress" exact="syndrome" post="do not survive. At the same time, patients die"/>
 <result pre="D-dimer, ferritin, lactate dehydrogenase (LDH), CRP, interleukin 1, interleukin 6," exact="tumor" post="necrosis factor alpha (TNF-alpha) and lymphopenia (12). A significant"/>
 <result pre="interleukin 1, interleukin 6, tumor necrosis factor alpha (TNF-alpha) and" exact="lymphopenia" post="(12). A significant number of people with COVID-19 do"/>
 <result pre="has been observed in previous coronavirus-related epidemics, namely SARS (Severe" exact="acute" post="respiratory syndrome) in 2003 and MERS (Middle East Respiratory"/>
 <result pre="been observed in previous coronavirus-related epidemics, namely SARS (Severe acute" exact="respiratory" post="syndrome) in 2003 and MERS (Middle East Respiratory Syndrome)"/>
 <result pre="(Severe acute respiratory syndrome) in 2003 and MERS (Middle East" exact="Respiratory" post="Syndrome) in 2012 (1). The phenomenon of â€žimmune stormâ€œ"/>
 <result pre="The phenomenon of â€žimmune stormâ€œ can be observed in other" exact="viral" post="infections, such as influenza. There are also non-infectious agents"/>
 <result pre="T lymphocytes that have been genetically modified to fight tumors," exact="leukemia" post="or lymphoma. 7. HYPERTENSION AND ANGIOTENTIN CONVERTING ENZYME-2 (ACE-2)"/>
 <result pre="been genetically modified to fight tumors, leukemia or lymphoma. 7." exact="HYPERTENSION" post="AND ANGIOTENTIN CONVERTING ENZYME-2 (ACE-2) Angiotensin converting enzyme-2 is"/>
 <result pre="(ACE-2) Angiotensin converting enzyme-2 is especially present in the lungs," exact="heart" post="and other tissues. It serves, among other things, as"/>
 <result pre="used in the treatment of hypertension, cardiac decompensation, after a" exact="myocardial infarction" post="and in chronic kidney disease. Both ACE inhibitors and"/>
 <result pre="of hypertension, cardiac decompensation, after a myocardial infarction and in" exact="chronic" post="kidney disease. Both ACE inhibitors and ARBs lead to"/>
 <result pre="hypertension, cardiac decompensation, after a myocardial infarction and in chronic" exact="kidney disease." post="Both ACE inhibitors and ARBs lead to increased ACE-2"/>
 <result pre="lungs from more serious injuries caused by the virus. 8." exact="HYPERTENSION" post="OFTEN OCCURS WITH COVID-19 According to reports from China,"/>
 <result pre="most common comorbidity in COVID-19 was hypertension, and patients with" exact="hypertension" post="required ventilatory support due to severe respiratory complications (1,"/>
 <result pre="and patients with hypertension required ventilatory support due to severe" exact="respiratory" post="complications (1, 20). At the same time, these patients"/>
 <result pre="time, these patients had increased mortality. The mechanism that connects" exact="hypertension" post="and COVID-19 is the immune system. Immune system dysregulation"/>
 <result pre="the immune system. Immune system dysregulation occurred in patients with" exact="hypertension" post="and COVID-19. Poor blood pressure control in these patients"/>
 <result pre="to further dysregulation of the immune system in these patients." exact="Hypertension" post="is associated with lymphocytes and CD8 + T cell"/>
 <result pre="of CD8 + T cells prevents them from effectively resisting" exact="viral infection." post="This contributes to pathological cytokine overproduction. Probably all this"/>
 <result pre="cytokine overproduction. Probably all this could explain the connection between" exact="hypertension" post="and COVID-19. It could be assumed that ACE inhibitors"/>
 <result pre="Society of Hypertension, the European Medicines Agency (EMA) and three" exact="American" post="Cardiac Associations: American Heart Association, American College of Cardiology"/>
 <result pre="of Hypertension, the European Medicines Agency (EMA) and three American" exact="Cardiac" post="Associations: American Heart Association, American College of Cardiology and"/>
 <result pre="the European Medicines Agency (EMA) and three American Cardiac Associations:" exact="American" post="Heart Association, American College of Cardiology and Heart Failure"/>
 <result pre="European Medicines Agency (EMA) and three American Cardiac Associations: American" exact="Heart" post="Association, American College of Cardiology and Heart Failure Society"/>
 <result pre="Agency (EMA) and three American Cardiac Associations: American Heart Association," exact="American" post="College of Cardiology and Heart Failure Society of America,"/>
 <result pre="Cardiac Associations: American Heart Association, American College of Cardiology and" exact="Heart Failure" post="Society of America, recommend not to stop taking ACE"/>
 <result pre="Associations: American Heart Association, American College of Cardiology and Heart" exact="Failure" post="Society of America, recommend not to stop taking ACE"/>
 <result pre="be given to patients infected with the SARS-CoV-2 virus. 10." exact="HYPERTENSION" post="AND SELF-ISOLATION Patients who have well controlled hypertension do"/>
 <result pre="virus. 10. HYPERTENSION AND SELF-ISOLATION Patients who have well controlled" exact="hypertension" post="do not require frequent check-ups. Many patients with hypertension"/>
 <result pre="controlled hypertension do not require frequent check-ups. Many patients with" exact="hypertension" post="due to COVID-19 are in self-isolation in order to"/>
 <result pre="go to their regular check-ups with the doctor. In addition," exact="hypertension" post="often occurs in the elderly (50% of people over"/>
 <result pre="develop hypertension) and at the same time the prevalence of" exact="hypertension" post="increases sharply in very old people. The old age"/>
 <result pre="values of ACE-2 are higher in diabetics and people with" exact="cardiovascular disease." post="The presence of hypertension, diabetes and coronary heart disease"/>
 <result pre="diabetics and people with cardiovascular disease. The presence of hypertension," exact="diabetes" post="and coronary heart disease contributes to the patientâ€™s poor"/>
 <result pre="people with cardiovascular disease. The presence of hypertension, diabetes and" exact="coronary heart disease" post="contributes to the patientâ€™s poor prognosis. Furthermore, increased D-dimer"/>
 <result pre="with cardiovascular disease. The presence of hypertension, diabetes and coronary" exact="heart" post="disease contributes to the patientâ€™s poor prognosis. Furthermore, increased"/>
 <result pre="cardiovascular disease. The presence of hypertension, diabetes and coronary heart" exact="disease" post="contributes to the patientâ€™s poor prognosis. Furthermore, increased D-dimer"/>
 <result pre="in D-dimer is a poor prognostic sign. The appearance of" exact="lymphopenia" post="and an increase of CRP also do not indicate"/>
 <result pre="and where there is a great need for oxygenation. As" exact="heart" post="damage has occurred, as itâ€™s mentioned earlier, it is"/>
 <result pre="an increase in IL-6 can have severe consequences for the" exact="cardiovascular" post="system. Tachycardia, atrial fibrillation, hypotension, and left ventricular dysfunction"/>
 <result pre="IL-6 can have severe consequences for the cardiovascular system. Tachycardia," exact="atrial fibrillation," post="hypotension, and left ventricular dysfunction may occur with concomitant"/>
 <result pre="for the cardiovascular system. Tachycardia, atrial fibrillation, hypotension, and left" exact="ventricular dysfunction" post="may occur with concomitant increase in GNP. In a"/>
 <result pre="every patient. Suppressing the immune system when the body fights" exact="infection" post="can lead to serious side effects and increase the"/>
 <result pre="lead to serious side effects and increase the risk of" exact="secondary" post="infection (19). In severe forms of COVID-19, Chinese doctors"/>
 <result pre="to serious side effects and increase the risk of secondary" exact="infection" post="(19). In severe forms of COVID-19, Chinese doctors in"/>
 <result pre="ORB International, in Europe in early April, 2020, while the" exact="infection" post="was still on the rise, show that resistance to"/>
 <result pre="family practitioners, epidemiologists, etc) with special preventive measures regarding COVID-19" exact="infection" post="(1). The severity of the primary respiratory syndrome and"/>
 <result pre="preventive measures regarding COVID-19 infection (1). The severity of the" exact="primary" post="respiratory syndrome and risk of adverse outcomes is increased"/>
 <result pre="measures regarding COVID-19 infection (1). The severity of the primary" exact="respiratory" post="syndrome and risk of adverse outcomes is increased in"/>
 <result pre="regarding COVID-19 infection (1). The severity of the primary respiratory" exact="syndrome" post="and risk of adverse outcomes is increased in patients"/>
 <result pre="is increased in patients infected with COVID-19 and with pre-existing" exact="cardiovascular" post="diseases. Patients with coronary artery disease and heart failure"/>
 <result pre="infected with COVID-19 and with pre-existing cardiovascular diseases. Patients with" exact="coronary artery disease" post="and heart failure may be at particular risk as"/>
 <result pre="with COVID-19 and with pre-existing cardiovascular diseases. Patients with coronary" exact="artery disease" post="and heart failure may be at particular risk as"/>
 <result pre="COVID-19 and with pre-existing cardiovascular diseases. Patients with coronary artery" exact="disease" post="and heart failure may be at particular risk as"/>
 <result pre="and with pre-existing cardiovascular diseases. Patients with coronary artery disease" exact="and heart" post="failure may be at particular risk as a result"/>
 <result pre="with pre-existing cardiovascular diseases. Patients with coronary artery disease and" exact="heart" post="failure may be at particular risk as a result"/>
 <result pre="at particular risk as a result of coronary plaque rupture," exact="secondary" post="to virally induced systemic inflammation, and rigorous use of"/>
 <result pre="a result of coronary plaque rupture, secondary to virally induced" exact="systemic" post="inflammation, and rigorous use of plaque stabilizing agents (aspirin,"/>
 <result pre="systolic impairment and reduced ejection fraction) (1). Pro-coagulant effects of" exact="systemic" post="inflammation may increase the likelihood of stent thrombosis and"/>
 <result pre="effects of systemic inflammation may increase the likelihood of stent" exact="thrombosis" post="and assessment of platelet function and intensified anti-platelet therapy"/>
 <result pre="and sponsorship: Nil. References REFERENCES 1.MasicINaserNZildzicMPublic Health Aspects of COVID-19" exact="Infection" post="with Focus on Cardiovascular DiseasesMater Sociomed20203321717610.5455/msm.2020.32.71-7632410896 2.MasicIGercVOn the Occasion"/>
 <result pre="(DMF) and Covid-19: is there a Possible Role?Med Arch2020474213413810.5455/medarh.2020.74.134-13832577056 4.SalihefendicNZildzicMAhmetagicSAcute" exact="Respiratory" post="Distress Syndrome (ARDS) from Endemic Influenza A/H1N1: Prehospital ManagementMed"/>
 <result pre="Covid-19: is there a Possible Role?Med Arch2020474213413810.5455/medarh.2020.74.134-13832577056 4.SalihefendicNZildzicMAhmetagicSAcute Respiratory Distress" exact="Syndrome" post="(ARDS) from Endemic Influenza A/H1N1: Prehospital ManagementMed Arh201526916263 5.https://avaz.ba/globus/svijet/574468/broj-mrtvih-od-koronavirusa-u-svijetu-premasio-400-000"/>
 <result pre="as a clinical presentation of mild-to-moderate forms of the coronavirus" exact="disease" post="(COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology10.1007/s00405-020-05965-1 7.KlokaFAKruipbMJHAvan"/>
 <result pre="in critically ill ICU patients with COVID-19Thrombosis Research202019114514710.1016/j.thromres.2020.04.01332291094 8.VargaZFlammerAJSteigerPHabereckerMEndothelial cell" exact="infection" post="and endotheliitis in COVID-19Lancet20203951417141832325026 9.ChenTWuDChenDClinical characteristics of 113 deceased"/>
 <result pre="in COVID-19Lancet20203951417141832325026 9.ChenTWuDChenDClinical characteristics of 113 deceased patients with coronavirus" exact="disease" post="2019: retrospective studyBMJ2020368109110.1136/bmj.m1091 10.Medical College Hospital for the management"/>
 <result pre="2019: retrospective studyBMJ2020368109110.1136/bmj.m1091 10.Medical College Hospital for the management of" exact="acute" post="myocardial infarction during the COVID-19 outbreakEuropean Heart J20201441191791179410.1093/eurheartj/ehaa25832232396 11.ClerkinKJFriedJARaikhelkarJCOVID-19"/>
 <result pre="retrospective studyBMJ2020368109110.1136/bmj.m1091 10.Medical College Hospital for the management of acute" exact="myocardial infarction" post="during the COVID-19 outbreakEuropean Heart J20201441191791179410.1093/eurheartj/ehaa25832232396 11.ClerkinKJFriedJARaikhelkarJCOVID-19 and Cardiovascular"/>
 <result pre="the management of acute myocardial infarction during the COVID-19 outbreakEuropean" exact="Heart" post="J20201441191791179410.1093/eurheartj/ehaa25832232396 11.ClerkinKJFriedJARaikhelkarJCOVID-19 and Cardiovascular DiseaseCirculation202014116481655https://doi.org/10.11615. The COVID-19 &amp;amp; AMI"/>
 <result pre="inhibitors of the reninâ€&quot;angiotensin systeme withdrawn in patients with COVID-19?Eur" exact="Heart" post="J2020411801180310.1093/eurheartj/ehaa23532196087 14.ZhouFYuTDuRFanGLiuYLiuZXiangJWangYSongBGuXGuanLWeiYLiHWuXXuJTuSZhangYChen 15.RuanQYangKWangWJiangLSongJ(2020) Clinical predictors of mortality due to"/>
 <result pre="https://www.medscape.com/viewarticle/927646 23.ESC Guidance for the Diagnosis and Management of CV" exact="Disease" post="during the COVID-19 PandemicEur Heart J202019822824https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. 2013 24.DiomidousMSleep and"/>
 <result pre="Diagnosis and Management of CV Disease during the COVID-19 PandemicEur" exact="Heart" post="J202019822824https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. 2013 24.DiomidousMSleep and Motion Disorders of Physicians and"/>
 <result pre="during the COVID-19 PandemicEur Heart J202019822824https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. 2013 24.DiomidousMSleep and Motion" exact="Disorders" post="of Physicians and Nurses Working in Hospitals Facing the"/>
</results>
